Middle East & Africa Influenza Vaccines Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis ­– by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People) 

No. of Pages: 135    |    Report Code: BMIRE00026955    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Influenza Vaccines Market

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Influenza Vaccines Market – By Vaccine Type

1.3.2        Middle East & Africa Influenza Vaccines Market – By Virus Type

1.3.3        Middle East & Africa Influenza Vaccines Market – By Technology

1.3.4        Middle East & Africa Influenza Vaccines Market – By Route of Administration

1.3.5        Middle East & Africa Influenza Vaccines Market – By Target Group

1.3.6        Middle East & Africa Influenza Vaccines Market – By Country

2.           Middle East & Africa Influenza Vaccines Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Influenza Vaccines Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa PEST Analysis

4.3         Experts Opinion

5.           Middle East & Africa Influenza Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Government Support to Promote Influenza Vaccination

5.1.2        Increasing Investment by Top Market Players and Governments

5.2         Market Restraints

5.2.1        High Cost of Vaccine Development

5.3         Market Opportunities

5.3.1        Emerging Economies

5.4         Future Trends

5.4.1        Strong Pipeline Candidates for Influenza Vaccines

5.5         Impact Analysis

6.           Influenza Vaccine Market – Middle East & Africa Analysis

6.1         Middle East & Africa Influenza Vaccines Market, By Country - Forecasts And Analysis

6.2         Middle East & Africa Influenza Vaccines Market Revenue Forecasts And Analysis

6.2.1        Middle East & Africa: Influenza Vaccines Market, 2019–2028 (US$ Million)

7.           Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 – By Vaccine Type

7.1         Overview

7.2         Middle East & Africa Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)

7.2.1        Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

7.3         Quadrivalent Vaccines

7.3.1        Overview

7.3.2        Quadrivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Trivalent Vaccines

7.4.1        Overview

7.4.2        Trivalent Vaccines : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.           Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 – By Virus Type

8.1         Overview

8.2         Middle East & Africa Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)

8.2.1        Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

8.3         Influenza Virus Type A

8.3.1        Overview

8.3.2        Influenza Virus Type A : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Influenza Virus Type B

8.4.1        Overview

8.4.2        Influenza Virus Type B : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.           Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 – By Technology

9.1         Overview

9.2         Middle East & Africa Influenza Vaccines Market, By Technology 2022 & 2028 (%)

9.2.1        Middle East & Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3         Egg-based

9.3.1        Overview

9.3.2        Egg-based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Cell-based

9.4.1        Overview

9.4.2        Cell-Based : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.        Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 – By Route of Administration

10.1      Overview

10.2      Middle East & Africa Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)

10.2.1     Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

10.3      Injection

10.3.1     Overview

10.3.2     Injection : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Nasal Spray

10.4.1     Overview

10.4.2     Nasal Spray: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.        Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 – By Target Group

11.1      Overview

11.2      Middle East & Africa Influenza Vaccines Market, By Target Group 2022 & 2028 (%)

11.2.1     Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

11.3      Infants

11.3.1     Overview

11.3.2     Infants : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.4      Children

11.4.1     Overview

11.4.2     Children: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.5      Adults

11.5.1     Overview

11.5.2     Adults : Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11.6      Elderly People

11.6.1     Overview

11.6.2     Elderly People: Middle East & Africa Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12.        Middle East & Africa Influenza Vaccines Market Analysis and Forecasts To 2028 – Country Analysis

12.1      Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028

12.1.1     Overview

12.1.2     Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)

12.1.2.1       Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.1       Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.2       Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

12.1.2.1.3       Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

12.1.2.1.4       Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.5       Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.6       Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.2       UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.1       UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.2       UAE: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

12.1.2.2.3       UAE: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

12.1.2.2.4       UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.5       UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.6       UAE: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.3       South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.1       South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.2       South Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

12.1.2.3.3       South Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

12.1.2.3.4       South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.5       South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.6       South Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

12.1.2.4       Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.1       Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.2       Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019–2028 (USD Million)

12.1.2.4.3       Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019–2028 (USD Million)

12.1.2.4.4       Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019–2028 (USD Million)

12.1.2.4.5       Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019–2028 (USD Million)

12.1.2.4.6       Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019–2028 (US$ Million)

13.        Middle East & Africa Influenza Vaccine Market –Industry Landscape

13.1      Overview

13.2      Growth Strategies in the Influenza Vaccine Market, 2021-2028

13.3      Inorganic Growth Strategies

13.3.1     Overview

13.4      Organic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      SEQIRUS

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Sanofi

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      GlaxoSmithKline plc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Mitsubishi Chemical Group Corporation

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Serum Institute of India Pvt. Ltd

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      MYLAN N.V.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      AstraZeneca

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms 

LIST OF TABLES

Table 1.             Middle East & Africa Influenza Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Table 2.             Middle East & Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Middle East & Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             Middle East & Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 5.             Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 6.             Middle East & Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Saudi Arabia Influenza Vaccine Market, by Virus Type– Revenue and Forecast to 2028 (USD Million)

Table 9.             Saudi Arabia Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 10.          Saudi Arabia Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 11.          Saudi Arabia Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 12.          UAE Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          UAE Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          UAE Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 15.          UAE Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 16.          UAE Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 17.          South Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Africa Influenza Vaccine Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Middle East & Africa Influenza Vaccine Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 26.          Rest of Middle East & Africa Influenza Vaccines Market, by Target Group– Revenue and Forecast to 2028 (USD Million)

Table 27.          Recent Inorganic Growth Strategies in the Influenza Vaccine Market

Table 28.          Recent Organic Growth Strategies in the Influenza Vaccine Market

Table 29.          Glossary of Terms, Influenza Vaccines Market 

LIST OF FIGURES

Figure 1.           Middle East & Africa Influenza Vaccines Market Segmentation

Figure 2.           Middle East & Africa Influenza Vaccines Market Segmentation, by Country

Figure 3.           Middle East & Africa Influenza Vaccines Market Overview

Figure 4.           Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Middle East & Africa Influenza Vaccines Market

Figure 5.           Saudi Arabia Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Middle East and Africa: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Middle East & Africa Influenza Vaccines Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 9.           Middle East & Africa Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)

Figure 10.        Quadrivalent Vaccines: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Trivalent Vaccines: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Middle East & Africa Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)

Figure 13.        Influenza Virus Type A : Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Influenza Virus Type B: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        Middle East & Africa Influenza Vaccines Market, by Technology 2022 & 2028 (%)

Figure 16.        Egg-based: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Cell-Based: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Middle East & Africa Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)

Figure 19.        Injection: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        Nasal Spray: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Middle East & Africa Influenza Vaccines Market, by Target Group 2022 & 2028 (%)

Figure 22.        Infants : Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        Children: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Adults: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Elderly People: Middle East & Africa Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        Middle East & Africa: Influenza Vaccine Market, by Key Country – Revenue (2022) (US$ Million)

Figure 27.        Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)

Figure 28.        Saudi Arabia: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        UAE: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        South Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Rest of Middle East & Africa: Influenza Vaccine Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Growth Strategies in the Influenza Vaccine Market, 2021-2028

The List of Companies - Middle East & Africa Influenza Vaccines Market

  1. AstraZeneca
  2. GlaxoSmithKline plc.
  3. Mitsubishi Chemical Group Corporation
  4. MYLAN N.V.
  5. Sanofi
  6. SEQIRUS
  7. Serum Institute of India Pvt. Ltd